Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on July 8, 2025
PharmStars Announces the First Startup from Korea to Graduate from its Accelerator Program: EXOSYSTEMS Inc.
EIN Presswire
·
July 8, 2025
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of EXOSYSTEMS Inc., the first Korean startup in the program. BOSTON, MA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- PharmStars, the pharma-focused …
LSI Consulting Recognized for Excellence in Customer Experience by Deep-Insight
EIN Presswire
·
July 8, 2025
LSI Ranks Among Top 10% in Customer Experience, Driven by Actionable Feedback and Collaborative Partnerships BOSTON, MA, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- LSI Consulting is proud to continue its partnership with Deep-Insight as part of …
TelluBase Launches New Features and Adds Latest Global Data in Semi-Annual Update
EIN Presswire
·
July 8, 2025
TelluBase is the subnational income distribution database from Tellusant, covering 218 countries, 2600 cities, and 2500 subdivisions 2000–2050. BOSTON, MA, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- Tellusant is proud to announce a major …
OnPage Recognized in 2025 Gartner Hype Cycle for Digital Care Delivery
EIN Presswire
·
July 8, 2025
Trusted by hospitals, OnPage powers faster clinical response to bridge the gap between urgent care needs and timely, coordinated action when every second counts WALTHAM, MA, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- OnPage Corporation, a …
MAJC Launches Digital Community Platform for Hospitality Professionals
GlobeNewswire
·
July 8, 2025
Hingham, MA, July 08, 2025 (GLOBE NEWSWIRE) -- MAJC, co-founded by award-winning chef Matt Jennings and tech entrepreneur Andy Coughlin, today announced the official launch of the MAJC Community. This first-of-its-kind digital platform connects and …
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
GlobeNewswire
·
July 8, 2025
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases …
Orezone Reports Q2-2025 Production and Hard Rock Expansion Update
GlobeNewswire
·
July 8, 2025
VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to announce its Q2-2025 gold production results and stage 1 hard rock expansion construction update at …
VERSES AI Inc. Announces Proposed Public Offering of Securities
GlobeNewswire
·
July 8, 2025
VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSD) (“VERSES” or the “Company”) is pleased to announce that it intends to offer and sell securities in an agency public offering to be undertaken on a …
Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock
GlobeNewswire
·
July 8, 2025
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an …
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
GlobeNewswire
·
July 8, 2025
TORONTO and HAIFA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical results demonstrating that 100% of small animals treated with a …
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager …
BenchPrep Expands Learning Platform with Enhanced Continuing Education Capabilities
GlobeNewswire
·
July 8, 2025
CHICAGO, July 08, 2025 (GLOBE NEWSWIRE) -- BenchPrep, an award-winning learning management system, today announced the expansion of its platform to power Continuing Education (CE) programs. With enhanced capabilities, credentialing bodies and professional …
Astera Labs Announces Conference Call to Review Second Quarter 2025 Financial Results
GlobeNewswire
·
July 8, 2025
SANTA CLARA, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the …
Vertex to Announce Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire
·
July 8, 2025
KING OF PRUSSIA, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release second quarter 2025 financial results before the market opens on …
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
GlobeNewswire
·
July 8, 2025
PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering with accredited investors for the …
Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the Company …
Accelevents Named a Grid Leader in G2’s Latest Report for Event Management Platforms
EIN Presswire
·
July 8, 2025
Accelevents announced today that its event management platform was recognized as a Grid Leader by G2, the world’s largest …
PS Miner announces rapid progress in its AI cloud mining infrastructure after raising $350 million in Series B funding
GlobeNewswire
·
July 8, 2025
London, UK, July 08, 2025 (GLOBE NEWSWIRE) -- PS Miner, a UK cloud mining platform headquartered in Southwark, London, was founded in 2019. On July 1, 2025, it announced the successful completion of its Series B financing, receiving $350 million to support …
TrueCommerce udnævner Bill Glass til CEO og markerer en ny fase af vækst og innovation
GlobeNewswire
·
July 8, 2025
KØBENHAVN, Danmark og PITTSBURGH, July 08, 2025 (GLOBE NEWSWIRE) -- TrueCommerce, en global leverandør af konnektivitet, integration og omnichannel-løsninger til forsyningskæden og handelspartnere, annoncerede i dag Bill Glass som administrerende direktør …